Influenza Activity — United States, 2012–13 Season and Composition of the 2013–14 Influenza Vaccine
Authors:
- Lynnette BrammerLBLynnette Brammer
- Krista KnissKKKrista Kniss
- Scott EppersonSEScott Epperson
- Lenee BlantonLBLenee Blanton
- Desiree MustaquimDMDesiree Mustaquim
- Craig SteffensCSCraig Steffens
- Tiffany D’MelloTDTiffany D’Mello
- Alejandro PerezAPAlejandro Perez
- Rosaline DharaRDRosaline Dhara
- Sandra S. ChavesSCSandra S. Chaves
- Anwar Abd ElalAEAnwar Abd Elal
- Larisa GubarevaLGLarisa Gubareva
- 14 June 2013
- journal article
- Vol. 62 (23) , 473-479
Abstract
During the 2012-13 influenza season in the United States, influenza activity* increased through November and December before peaking in late December. Influenza A (H3N2) viruses predominated overall, but influenza B viruses and, to a lesser extent, influenza A (H1N1)pdm09 (pH1N1) viruses also were reported in the United States. This influenza season was moderately severe, with a higher percentage of outpatient visits for influenza-like illness (ILI), higher rates of hospitalization, and more reported deaths attributed to pneumonia and influenza compared with recent years. This report summarizes influenza activity in the United States during the 2012-13 influenza season (September 30, 2012-May 18, 2013) as of June 7, 2013, and reports the recommendations for the components of the 2013-14 Northern Hemisphere influenza vaccine.Keywords
This publication has 4 references indexed in Scilit:
- Clinical Findings in 111 Cases of Influenza A (H7N9) Virus InfectionNew England Journal of Medicine, 2013
- Influenza A (H3N2) variant virus-related hospitalizations: Ohio, 2012.2012
- Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).2011
- Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.2010